Objective: To evaluate the correlation of raised CRP levels in premenopausal and postmenopausal females with hypothyroidism and to assess the future risk of adverse coronary events amongst them.
INTRODUCTION
CRP is called as C-reactive protein, is an inflammatory marker, produced by hepatocytes and is an acute phase reactant. Despite its name it is found to be elevated in both acute and chronic inflammation. More than 30 epidemiological studies have been done so far for association of raised CRP levels and adverse coronary events, but very few studies have shown importance of raised CRP levels in hypothyroidism and none have evaluated raised CRP levels in premenopausal and postmenopausal females with hypothyroidism. It has been found that population with raised CRP levels is associated with high risk of adverse coronary events. Adverse coronary events in our study are described as acute onset of myocardial infarction, unstable/stable angina, stroke, transient is chemic attack, congestive heart failure. There is an increased evidence of raised CRP levels and its association with recurrent episodes of cardiovascular morbidity in patients with established cardiovascular disease and in patients without any history of cardiovascular disease but having other conventional risk factors for cardiovascular disease. [1] studies have shown that CRP levels were found to be raised in postmenopausal females taking hormone replacement therapy,in middle aged males,females having high body mass index,high subcutaneous and visceral fat.A strong negative predictor was found to be high density lipoprotein for CRP.Despite of extensive studies on raised CRP levels and its association with adverse coronary events as described above,it lacks specificity for cardiovascular diseases but its role in development of atherosclerosis and plaque's rupture in atherosclerosed vessels is strong and it is a systemic as well as local inflammatory marker in the development of atherosclerosis.
Hypothyroidism is defined as raised TSH levels above the reference value (0.4-5.5micro international unit per millilitre) with or without decrease in free T4 levels.Patients with only raised TSH values and clinical symptoms of hypothyroid are considered to have subclinical hypothyroidism and included in our study.
II. METHODOLOGY
The study was conducted in department of cardiology band medicine, Gandhi medical college, Hamidia hospital, Bhopal from October 2013 to September 2014.It was a prospective-observational, cross sectional, analytical study on 90 premenopausal females with hypothyroidism and 90 postmenopausal females with hypothyroidism and 90 premenopausal and 90 postmenopausal females of age matched control groups from hospital staff and opd's, without having hypothyroism and other conventional risk factors for cardiovascular diseases like DM2, Hypertension, hyperlipedemia and high body mass index and other systemic illnesses. Purpose of study was explained to study group and control group and informed consent was obtained. 
VI. DISCUSSION
Total number of hypothyroid premenopausal females with raise CRP levels are 12 and 13.3% .Total number of euthyroid females from control group with raised CRP levels are 3 and 3.3%.
Total number of hypothyroid postmenopausal females with raised CRP are 22 and 24.4%,whereas euthyroid postmenopausal females from control group are 9 and 10%.As shown in above tables p value for premenopausal females with hypothyroidism is 0.031 which is significant and in post menopausal females with hypothyroidism is 0.01 which is also significant.
Postmenopausal females with hypothyroidism with DM 2 are 42 and 46.7% with p value 0.032and in premenopausal females with hypothyroidism with DM 2 are 33 and 36.7% with p value 0.004.
IT is significantly found that the raised CRP levels are present in our study group along with the DM 2.After regression analysis BMI ,Hypertension and dyslipidemia are significantly responsible in post menopausal group for raised CRP levels.Many of the premenopausal group in early 30's had presented with metabolic syndrome along with the hypothyroidism which is responsible for the raise CRP levels amongst them and their risk for developing adverse coronary events as mentioned above , in future.So this group is particularly important for long term.
VII. CONCLUSION
Above findings have suggested that there should be active interventions to screen pre and postmenopausal females for raised CRP levels in hypothyroidism to prevent future risk of adverse coronary events.In significant number of premenopausal and postmenopausal females with hypothyroidism DM2 is present which is again an independent risk factor for both raised CRP levels and adverse coronary events.However further studies need to be conducted and follow up of these cases are required to look for adverse coronary events.Above tables have also includes body mass index,systolic and diastolic blood pressures,lipid profiles with left ventricular ejection fractions.
